Skip to main content

Closed

JSPR: Jasper Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-564.2%

Financially safe

Stretched

Debt / equity0.22×

Interest coverage0.0×

Current ratio2.26×

Jasper Therapeutics, Inc.

JSPRNASDAQ·USD·Closed

Jasper Therapeutics, Inc.

JSPRNASDAQ·USD·Closed

$0.63

+1.48%

$0.63

+$0.01 (1.48%)

52W Range

11thpctl

Volume

0.37×avg

Mkt Cap

10.24MUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

11thpctl

Volume

0.37×avg

Market Cap

10.24MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings